Cargando…
Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand Disease
Background The efficacy and safety of wilate (human von Willebrand factor/coagulation factor VIII) in patients with von Willebrand disease (VWD) has been demonstrated in clinical trials. Here, we present real-world data on the use of wilate for the routine care of patients with VWD. Objectives The...
Autores principales: | Sholzberg, Michelle, Khair, Kate, Yaish, Hassan, Rodgers, George, Cruz, Maria Sol, Mejía, Cesar Montaño, Čermáková, Zuzana, Matino, Davide, Teitel, Jerome, Barrie, Alpha, Werner, Sylvia, Prondzinski, Mario von Depka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255103/ https://www.ncbi.nlm.nih.gov/pubmed/34235395 http://dx.doi.org/10.1055/s-0041-1730283 |
Ejemplares similares
-
Desmopressin responsiveness by age in type 1 von Willebrand disease
por: Goldberg, Nicola, et al.
Publicado: (2020) -
Lymphoma‐associated acquired von Willebrand syndrome responsive to splenectomy: A case report
por: Khadadah, Fatima, et al.
Publicado: (2022) -
A 12.3-kb Duplication Within the VWF Gene in Pigs Affected by Von Willebrand Disease Type 3
por: Lehner, Stefanie, et al.
Publicado: (2017) -
Sixth Åland Island Conference on von Willebrand disease
por: Berntorp, Erik, et al.
Publicado: (2022) -
Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019)